ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 27 filers reported holding ELEVATION ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,930,985 | -56.4% | 2,914,255 | 0.0% | 0.55% | -65.8% |
| Q2 2023 | $4,429,668 | +24.9% | 2,914,255 | +56.1% | 1.60% | -18.4% |
| Q1 2023 | $3,546,044 | +100.0% | 1,866,339 | 0.0% | 1.96% | +257.3% |
| Q4 2022 | $1,773,022 | -15.9% | 1,866,339 | 0.0% | 0.55% | +12.7% |
| Q3 2022 | $2,109,000 | -19.3% | 1,866,339 | 0.0% | 0.49% | -34.4% |
| Q2 2022 | $2,613,000 | -60.2% | 1,866,339 | -28.4% | 0.74% | -48.9% |
| Q1 2022 | $6,573,000 | -58.1% | 2,608,167 | 0.0% | 1.46% | -48.5% |
| Q4 2021 | $15,701,000 | -22.7% | 2,608,167 | 0.0% | 2.83% | +39.8% |
| Q3 2021 | $20,318,000 | -42.6% | 2,608,167 | 0.0% | 2.02% | -51.5% |
| Q2 2021 | $35,393,000 | – | 2,608,167 | – | 4.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,834,910 | $22,084,000 | 4.40% |
| venBio Partners LLC | 2,608,167 | $20,318,000 | 2.02% |
| Samsara BioCapital, LLC | 932,240 | $7,262,000 | 1.14% |
| Cormorant Asset Management, LP | 1,983,165 | $15,140,000 | 0.62% |
| BVF INC/IL | 1,590,298 | $12,388,000 | 0.48% |
| Boxer Capital, LLC | 1,341,530 | $10,451,000 | 0.36% |
| CAXTON CORP | 48,183 | $375,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,997,564 | $15,561,000 | 0.18% |
| Vivo Capital, LLC | 496,843 | $3,870,000 | 0.17% |
| CAAS CAPITAL MANAGEMENT LP | 60,000 | $467,000 | 0.01% |